Interpace Biosciences Inc.

10/21/2021 | Press release | Distributed by Public on 10/21/2021 07:18

Interpace Diagnostics Announces US Patent Approval for Patent Application No. 11,118, 231 B2 Titled: microRNAs as Biomarkers for Distinguishing Benign from Malignant Thyroid[...]